Product Overview
This product is a synthetic peptide with the molecular formula C269H381N67O82S2. The peptide sequence is Tyr-Leu-Tyr-Gln-Trp-Leu-Gly-Ala-Pro-Val-Pro-Tyr-Pro-Asp-Pro-Leu-{Gla}- Pro-Arg-Arg-{Gla}-Val-Cys-{Gla}-Leu-Asn-Pro-Asp-Cys-Asp-Glu-Leu-Ala-Asp-His-Ile-Gly-Phe-Gln-Glu-Ala-Tyr-Arg-Arg-Phe-Tyr-Gly-Pro-Val (Disulfide bridge:Cys23-Cys29).
Tag/Conjugate
Unonjugated
Alternative Names
Osteocalcin; Osteocalcin (1-49)
Purity
>95% as determined by HPLC
Storage
Sealed storage, away from moisture.
Store at -80°C for 2 years, store at -20°C for 1 year.
Reconstitution
DMSO : 100 mg/mL (16.86 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Introduction
Osteocalcin (1 nM-1 μM) is chemotactic for breast cancer cells and osteoblast-like osteogenic sarcoma cells as well as monocytes, and causes their unidirectional migration.
Osteocalcin peptide contains 49 amino acids, with subsequent breakdown to fragments 1-19, 20-49, 20-43, 1-43, and 44-49 in the liver, kidney, and serum.
Keywords
Osteocalcin; Osteocalcin (1-49)
Citations
Publication ()
Have you cited DAGC-Y26002 in a publication?
Let us know and earn a reward for your research.